Screening for a drug is often likened to searching for ... an approach that Taylor refers to as "high-content screening [or HCS]." The idea is to automate the experiments that would be the focus ...

Whether you’re measuring shape-shifting in a single dish of cells or treating a multiwell plate of them with thousands of different compounds to identify drug targets, analyzing a single readout ...

In drug discovery, and in biological experimentation in general, cell-based assays are replacing conventional in vitro binding or enzyme assays more and more. New fluorescent probes as well as ...

Our Drug Sensitivity and Resistance Testing (DSRT) platform allows doctors and researchers to test pharmacological dependencies of cancer cells. Allow cookies to display content This content is ...

View your results and make key decisions while other systems are still spooling and importing files for analysis. Analysis and screening: The CellInsight CX7 High-Content Platform with HCS Studio Cell ...

to enable bona fide chemical probe and early drug discovery in oncology. Moreover, considering that the microscopy has provided the morphological underpinning to the study of cancer biology, therefore ...

Biologics researchers face the daunting task of narrowing down a vast pool of antibodies and proteins, often numbering in the millions, to just a few hundred for high-throughput screening.